Latanoprost Accord-Uk

Latanoprost, the active ingredient in Latanoprost Accord-Uk, is a prostaglandin analog presented as eye drops for ocular use. It is employed to lower intra‑ocular pressure in patients with open‑angle glaucoma or ocular hypertension, helping to preserve visual function. The medication is typically administered as a single drop in the affected eye once daily.

GNH USA supplies Latanoprost Accord-Uk as a licensed, GDP‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under strict quality‑assurance standards and regulatory oversight.

Latanoprost is a prostaglandin analog used to manage ocular conditions characterized by elevated intra‑ocular pressure.

Open‑angle glaucoma: reduces intra‑ocular pressure to slow disease progression. Ocular hypertension: lowers pressure to prevent conversion to glaucoma. Secondary ocular hypertension: helps control pressure when caused by other ocular conditions.

Latanoprost may cause a range of ocular and systemic reactions.

Common Side Effects: - Eye redness or hyperemia. - Increased eyelash length and thickness. - Darkening of the iris pigment. - Eye irritation or foreign‑body sensation. - Blurred vision. - Mild ocular discomfort.

Serious or Rare Side Effects: - Severe allergic reaction with swelling or rash. - Paradoxical increase in intra‑ocular pressure. - Corneal edema or clouding. - Anterior uveitis. - Sudden loss of vision. - Persistent eye pain.

Before using Latanoprost, consider the following safety measures.

Monitor IOP: regular measurement of intra‑ocular pressure is essential. Assess iris color: note potential permanent darkening of the iris. Check for ocular infection: avoid use if active infection is present. Avoid contact lenses: discontinue lens wear during treatment. Pregnancy: use only if the potential benefit justifies the potential risk. Store at room temperature: keep in the original container, protect from light and moisture.

Latanoprost may interact with other ophthalmic agents.

Major Interactions (Avoid): - Concomitant use of other prostaglandin analogs: additive pressure‑lowering may cause hypotony. - Use with ocular anesthetics containing preservatives: increased ocular irritation.

Moderate Interactions (Monitor Closely): - Non‑steroidal anti‑inflammatory eye drops: may reduce Latanoprost efficacy. - Systemic beta‑blockers: additive ocular hypotensive effect. - Topical corticosteroids: may counteract intra‑ocular pressure reduction.